{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:16:58Z","timestamp":1783772218330,"version":"3.55.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2016,4,27]]},"DOI":"10.2174\/1381612822666160203142111","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T02:29:00Z","timestamp":1454984940000},"page":"2411-2430","source":"Crossref","is-referenced-by-count":37,"title":["Pharmacotherpy and Alzheimer's Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach"],"prefix":"10.2174","volume":"22","author":[{"given":"Mak","family":"Adam Daulatzai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/139136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T07:51:24Z","timestamp":1493193084000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=22&issue=16&spage=2411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":0,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,4,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612822666160203142111","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,27]]}}}